Markets:

Overview

News

Currencies

International

Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

585.99 -5.21 (-0.88%)

Delayed Quote Updated: 12:15 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022

December 03, 2021

From United Therapeutics Corporation

Via Business Wire

Liquidia's Inhaled Treprostinil Powder Scores Tentative FDA Approval For PAH ↗

November 08, 2021

The FDA has granted tentative approval to Liquidia Corporation's (NASDAQ: LQDA) Yutrepia (treprostinil) inhalation powder for pulmonary arterial...

Via Benzinga

United Therapeutics Corporation (UTHR) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

UTHR earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

Recap: United Therapeutics Q3 Earnings ↗

November 03, 2021

United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the announcement...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates ↗

November 02, 2021

The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...

Via Benzinga

Why Shares of MannKind Corporation Are Falling This Morning ↗

October 18, 2021

Investors are hyperventilating after a delay for its inhaled medicine.

Via The Motley Fool

FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease ↗

October 18, 2021

The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ: UTHR) regarding the marketing application for Tyvaso DPI for pulmonary...

Via Benzinga

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates ↗

October 01, 2021

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...

Via Benzinga

Acceleron Stock Heats Up On $11 Billion Takeover Rumor; So, Who's The Buyer? ↗

September 27, 2021

A biotech working in lung and blood diseases, as well as cancer, could be acquired.

Via Investor's Business Daily

United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients ↗

September 07, 2021

United Therapeutics Corporation (NASDAQ: UTHR) has presented new clinical data from the BREEZE study evaluating Tyvaso DPI (treprostinil) in patients with pulmonary...

Via Benzinga

Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments

August 05, 2021

Via FinancialNewsMedia

88 Biggest Movers From Yesterday ↗

August 05, 2021

Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...

Via Benzinga

Why United Therapeutics Blasted 14% Higher Today ↗

August 04, 2021

Every one of the company's products booked a revenue gain in Q2.

Via The Motley Fool

United Therapeutics Corporation (UTHR) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

UTHR earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

United Therapeutics: Q2 Earnings Insights ↗

August 04, 2021

Shares of United Therapeutics (NASDAQ:UTHR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 11.14% over the past...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mostly lower Ahead Of General Motors Earnings ↗

August 04, 2021

Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade after the Dow Jones surged around 280 points in the previous session. Investors are awaiting...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

Earnings Scheduled For August 4, 2021 ↗

August 04, 2021

Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 ↗

July 14, 2021

Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:

Via Benzinga

MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension ↗

June 16, 2021

MannKind Corporation (NASDAQ: MNKD) and United Therapeutics Corporation (NASDAQ: UTHR) have announced that the FDA has accepted for review the marketing...

Via Benzinga

Price Over Earnings Overview: United Therapeutics ↗

May 06, 2021

Looking into the current session, United Therapeutics Inc. (NASDAQ:UTHR) is trading at $193.48, after a 2.35% decrease. Over the past month, the stock fell by 3.61...

Via Benzinga

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

May 06, 2021

Rosenblatt lifted the price target on Qorvo Inc (NASDAQ: QRVO) from $175 to $200. Qorvo shares rose 0.8% to $184.01 in pre-market trading. Needham boosted HubSpot Inc (NASDAQ:...

Via Benzinga

United Therapeutics Corp (UTHR) Q1 2021 Earnings Call Transcript ↗

May 05, 2021

UTHR earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

United Therapeutics: Q1 Earnings Insights ↗

May 05, 2021

Shares of United Therapeutics (NASDAQ:UTHR) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were down 3.32% year over year to $3....

Via Benzinga

A Peek Into The Markets: US Stock Futures Gain; General Motors Earnings In Focus ↗

May 05, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq dipped more than 260 points in the previous session. Investors are awaiting earnings...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.